## SNPS: Synopsys, Inc. - XLK: Technology

### Executive Summary

STRENGTH thesis confirmed: MRS_20 at 9.1% in upper entry zone (4.0-10.0%), top 6% cross-sectional ranking. Caution: MRS_5 (-0.2%) diverging from MRS_20, watch for reversal. Outperforming sector by 7.8%. Caution: momentum weakening (-3.9% MRS).

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($436.73)
- **If Wrong:** Exit if MRS_20 drops below entry zone or breaks stop
- **Invalidation:** MRS_20 exits entry zone or MRS_5 turns negative

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Citi upgrades Synopsys to Neutral ahead of its Q4 earnings (SNPS:NASDAQ)**
- Source: Seeking Alpha | 20251208T152831 | Neutral | Relevance: 99%
- Citi has upgraded Synopsys (SNPS) to Neutral from Underperform in anticipation of its upcoming Q4 fiscal 2025 earnings report. The upgrade is based on the expectation that Synopsys's fiscal 2026 outlook might address concerns regarding weakness in its China and Intel IP business, as well as Ansys integration costs. The analyst also notes the potential impact of Nvidia's $2 billion investment and partnership, although viewing it as tactical rather than a guaranteed long-term differentiator.

**2. Shareholders SueWallSt in New Class Action Against Synopsys, Inc. - Act Now**
- Source: mypanhandle.com | 20251208T231528 | Neutral | Relevance: 99%
-  A class action lawsuit has been filed against Synopsys, Inc. on behalf of investors who allegedly suffered losses due to securities fraud between December 4, 2024, and September 9, 2025. The law firm Levi & Korsinsky is representing the investors and encourages those affected to contact them for more information.

**3. Levi & Korsinsky Notifies Synopsys, Inc. (SNPS) Shareholders of Class Action Lawsuit and December 30, 2025 Deadline**
- Source: CBS 42 | 20251207T160808 | Neutral | Relevance: 99%
-  Levi & Korsinsky LLP has announced a class action lawsuit against Synopsys, Inc. (NASDAQ: SNPS) on behalf of shareholders who suffered losses between December 4, 2024, and September 9, 2025. The lawsuit alleges that Synopsys made misleading statements regarding the financial impact of increased customization for AI customers on its Design IP business. Shareholders affected by these alleged securities frauds have until December 30, 2025, to seek a recovery without cost or obligation.

**4. Shareholders SueWallSt in New Class Action Against Synopsys, Inc. - Act Now**
- Source: Nasdaq | 20251208T222543 | Neutral | Relevance: 99%
-  A class action lawsuit has been filed against Synopsys, Inc. on behalf of investors who allegedly suffered losses due to securities fraud between December 4, 2024, and September 9, 2025. Investors are encouraged to contact Levi & Korsinsky to learn more or to take action. Levi & Korsinsky is a law firm specializing in complex securities litigation with a track record of securing significant recoveries for aggrieved shareholders.

**5. SNPS Investors Have Opportunity to Lead Synopsys, Inc. Securities Fraud Lawsuit**
- Source: FOX40 News | 20251207T110857 | Neutral | Relevance: 99%
-  The Rosen Law Firm is reminding purchasers of Synopsys, Inc. (NASDAQ: SNPS) securities who bought between December 4, 2024, and September 9, 2025, that the lead plaintiff deadline for a securities fraud lawsuit is December 30, 2025. The lawsuit alleges that Synopsys made materially false and misleading statements regarding its business operations, particularly concerning the impact of increased focus on AI customers on its Design IP business economics. Investors who suffered losses are encouraged to contact the Rosen Law Firm to explore their options to join the class action.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 4)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-09 | Rosenblatt | $560 | $605 | -7% |
| 2025-12-08 | B of A Securiti | $500 | $525 | -5% |
| 2025-12-03 | Keybanc | $575 | $590 | -3% |
| 2025-11-25 | Wells Fargo | $445 | $550 | -19% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-09 | Rosenblatt | up | Buy |
| 2025-12-08 | B of A Securiti | up | Neutral |
| 2025-12-03 | Keybanc | main | Overweight |
| 2025-11-25 | Wells Fargo | main | Equal-Weight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 5 ($0.69M) |
| Sells | 3 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 40.5% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Vanguard Group Inc: 9.8% (+20.7%)
- Blackrock Inc.: 8.2% (+18.5%)
- State Street Corpora: 4.7% (+20.6%)
- Capital World Invest: 4.0% (-3.7%)
- FMR, LLC: 3.1% (+47.5%)

### Key Risks

1. Valuation stretched: PEG 6.1x requires aggressive growth execution.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 6.11 signals overvaluation risk, limited margin of safety. Forward P/E 33.1x stretched relative to 9% growth. Quality metrics strong (margin 31%). Revenue growth strong at 37% YoY. Analyst sentiment negative (4 target cuts vs 0 raises). Insider buying signal ($0.7M), management confidence. Institutional flow bullish (8 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $88.8B |
| Beta | 1.15 |
| 52W Range | $365.74 - $651.73 |
| Short Interest | 2.3% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 6.11 |
| Forward P/E | 33.1 |
| Current P/E | 36.3 |
| YoY Growth | 9.4% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 13.1% to 9.1% (-3.9% in 5 days), indicating relative weakness vs NASDAQ. Currently in upper STRENGTH zone (4.0-10.0%), cross-sectional ranking at 93rd percentile. MRS_5 (-0.2%) diverging from MRS_20 - short-term weakness emerging. AM_20 at 11.4% shows strong absolute momentum above own 20MA. Outperforming sector by 7.8pp, stock-specific strength. Below SMA200 (0.95x), long-term trend not supportive. MACD histogram positive (9.58), confirming momentum.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 9.13% (CS: 94) | Strong |
| RSI_14 | 67.2 | Neutral |
| MACD Histogram | 9.58 | Bullish |
| vs SMA20 | 1.114x | Above |
| vs SMA50 | 1.064x | Above |
| vs SMA200 | 0.954x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $465.85
- **Stop Loss:** $436.73 (6.3% risk)
- **Target:** $509.53 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 41
- **Position Value:** $19,099.85
- **Portfolio %:** 19.10%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite. VIX remains in the mid-range, breadth is moderate, and yield curve is flat but not invertedâ€”indicating standard late-cycle conditions. Upbeat earnings and positive tech momentum are offset by cautious guidance in consumer sectors, suggesting selective positioning is favored.*

### Earnings

**Next:** 2025-12-10 (Est: $2.88)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $3.75 | $3.39 | -9.5% |
| 2025Q2 | $3.40 | $3.67 | +8.0% |
| 2025Q1 | $2.79 | $3.03 | +8.6% |
| 2024Q4 | $3.30 | $3.40 | +3.0% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*